Kyung Dong Pharmaceutical Co. Ltd (011040) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.011x

Based on the latest financial reports, Kyung Dong Pharmaceutical Co. Ltd (011040) has a cash flow conversion efficiency ratio of 0.011x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.45 Billion ≈ $1.66 Million USD) by net assets (₩228.87 Billion ≈ $155.10 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Kyung Dong Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Kyung Dong Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Kyung Dong Pharmaceutical Co. Ltd for a breakdown of total debt and financial obligations.

Kyung Dong Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Kyung Dong Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shine Justice Ltd AU:SHJ	-0.049x
KAISA GROUP HLDGS F:KG5	N/A
Apex Biotechnology Corp TW:1733	0.003x
Pinar Sut Mamulleri Sanayi AS IS:PNSUT	0.025x
Bathurst Resources Ltd F:B0R	0.017x
Intertek Group PLC LSE:ITRK	0.124x
Q.BEYOND AG NA O.N. KONV. XETRA:QBY0	0.035x
CDON AB ST:CDON	-0.042x

Annual Cash Flow Conversion Efficiency for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Kyung Dong Pharmaceutical Co. Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Kyung Dong Pharmaceutical Co. Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩228.87 Billion ≈ $155.10 Million	₩16.93 Billion ≈ $11.48 Million	0.074x	+301.66%
2024-12-31	₩220.06 Billion ≈ $149.13 Million	₩-8.07 Billion ≈ $-5.47 Million	-0.037x	-26148.62%
2023-12-31	₩228.48 Billion ≈ $154.84 Million	₩-31.94 Million ≈ $-21.64K	0.000x	+96.66%
2022-12-31	₩257.20 Billion ≈ $174.30 Million	₩-1.07 Billion ≈ $-728.49K	-0.004x	-108.74%
2021-12-31	₩259.82 Billion ≈ $176.08 Million	₩12.42 Billion ≈ $8.42 Million	0.048x	-26.76%
2020-12-31	₩262.19 Billion ≈ $177.68 Million	₩17.12 Billion ≈ $11.60 Million	0.065x	+632.25%
2019-12-31	₩226.71 Billion ≈ $153.64 Million	₩-2.78 Billion ≈ $-1.88 Million	-0.012x	-107.81%
2018-12-31	₩211.72 Billion ≈ $143.48 Million	₩33.27 Billion ≈ $22.55 Million	0.157x	+134.79%
2017-12-31	₩220.95 Billion ≈ $149.74 Million	₩14.79 Billion ≈ $10.02 Million	0.067x	-45.18%
2016-12-31	₩209.93 Billion ≈ $142.26 Million	₩25.63 Billion ≈ $17.37 Million	0.122x	+37.17%
2015-12-31	₩205.14 Billion ≈ $139.02 Million	₩18.26 Billion ≈ $12.37 Million	0.089x	-25.43%
2014-12-31	₩190.43 Billion ≈ $129.05 Million	₩22.73 Billion ≈ $15.40 Million	0.119x	+22.85%
2013-12-31	₩169.03 Billion ≈ $114.55 Million	₩16.42 Billion ≈ $11.13 Million	0.097x	-25.16%
2012-12-31	₩153.76 Billion ≈ $104.20 Million	₩19.96 Billion ≈ $13.53 Million	0.130x	-25.02%
2011-12-31	₩150.62 Billion ≈ $102.07 Million	₩26.08 Billion ≈ $17.67 Million	0.173x	--

About Kyung Dong Pharmaceutical Co. Ltd

KQ:011040 Korea Pharmaceuticals

Market Cap

$89.89 Million

₩132.64 Billion KRW

Market Cap Rank

#19604 Global

#1102 in Korea

Share Price

₩5640.00

Change (1 day)

+0.36%

52-Week Range

₩5290.00 - ₩6200.00

All Time High

₩14206.86